Lawson MacArtney, Director at Viking Therapeutics, Inc. (VKTX), bought 95,930 shares at $5.22 ($501K) on 2018-05-29, disclosed to the SEC on 2018-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.22 | 47,965 | $250K | 50.0% |
| 2 | $5.22 | 47,965 | $250K | 50.0% |
| Total | $5.22 avg | 95,930 | $501K | 100% |
| Filing → |
| VKTX | SELL | 2023-04-24 | $352K | — | Filing → |
| VKTX | SELL | 2023-04-18 | $416K | — | Filing → |